真实世界数据对临床研究的真实影响

Learn how Citeline’s Real-World Data (RWD) can inform your clinicaldevelopment strategy and differentiate your target product profile Use Case| RWD for Early Clinical Development Planning & Strategy Situation A client was challenged with understanding the existing market in the pancreatic ductaladenocarcinoma (PDAC) space. The company has a novel platform and wanted tounderstand an early target product profile: Is the unmet need high enough? What are the baseline metrics for market positioning? How are patients being treated today and will that change in the near future? Use Case| RWD for Early Clinical Development Planning & Strategy Solution To answer these key questions, we employed a comprehensiveand multifaceted patient journey mapping project, leveragingcutting-edge techniques in: Real-world data analysisUsing Citeline’s RWD asset to obtain a representative picture of how patients navigate through their healthcarejourney, treatment patterns, disease progression, healthcareutilization, and patient outcomes in real-world settings Trial and market intelligenceIntegrating data from Citeline’s proprietary databases, Trialtrove and Sitetrove, to enrich the patient journeyanalysis with context from ongoing clinical trials,competitor landscape, and market dynamics Primary researchEngaging directly with patients, healthcare providers, and other stakeholders utilizing qualitative and quantitativemethods to provide a more profound understanding ofpatients’ emotional and practical challenges, treatmentpreferences, and decision-making processes Use Case| RWD for Early Clinical Development Planning & Strategy Value In the end, our structured patient journey mapping approach produced actionable insightsfor the client’s clinical development strategy, including but not limited to: Overviewof real-world PDAC patient population,journey, outcomes, and opportunities Understandingof the PDAC market, productpositioning, and clinical endpoints Awarenessof new and anticipated developmentmilestones to inform decision-making Use Case| RWD for Early Clinical Development Planning & Strategy The Citeline Difference Tap into unique combination of powerful, granulardata sourcesto generate nuanced insights Work with adedicated team of expertswith hundreds of years of combinedclinical and commercial expertise, delivering insights how you need them Utilize support throughout the R&D lifecycle– from initial strategy/commercial analysis to clinical development and disclosure 5Copyright © 2023 Citeline, a Norstella company. ( U nauthorized p h otocopying p rohibited).Learn how Citeline’s RWD can inform your clinical developmentstrategy and differentiate your target product profile Citeline, aNorstellacompany, powers a full suite ofcomplementary business intelligence offerings to meet theevolving needs of life science professionals to accelerate theconnection of treatments to patients and patients to treatments.These patient-focused solutions and services deliver and analyzedata used to drive clinical, commercial and regulatory-relateddecisions and create real-world opportunities for growth. Our global teams of analysts, journalists and consultants keeptheir fingers on the pulse of the pharmaceutical, biomedicaland medtech industries, covering it all with expert insights: keydiseases, clinical trials, drug R&D and approvals, market forecastsand more. For more information on one of the world’s most trustedlife science partners, visitCiteline.com